Brought to you by 
Intact Vascular closes $38.9mm Series B; closes round at $46mm
21 Apr 2021
Executive Summary
Intact Vascular Inc. (minimally invasive surgical devices for peripheral vascular disease) raised $38.9mm in its Series B financing led by new backer New Enterprise Associates, which adds a board member and was joined by returning shareholders Quaker Partners, HIG BioVentures, and others. Funds will help the company finish developing and gain FDA approval for its Tack Endovascular System for angioplasty in PAD patients.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Intact Vascular closes $38.9mm Series B; closes round at $46mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice